Search

Your search keyword '"Helvaci, K."' showing total 31 results

Search Constraints

Start Over You searched for: Author "Helvaci, K." Remove constraint Author: "Helvaci, K." Language english Remove constraint Language: english
31 results on '"Helvaci, K."'

Search Results

1. Comparison of clinicopathological and survival features of right and left colon cancers

2. Impact of adjuvant treatment modalities on survival outcomes in

3. Prognostic factors in patients with advanced pancreatic cancer treated with gemcitabine alone or gemcitabine plus cisplatin: retrospective analysis of a multicenter study

7. Gemcitabine Alone versus combination of Gemcitabine and Cisplatin for the Treatment of Patients with Locally Advanced and/or Metastatic Pancreatic Carcinoma: A Retrospective Analysis of multicenter study

10. The efficacy of immunotherapy and chemoimmunotherapy in patients with advanced rare tumors: A Turkish oncology group (TOG) study.

11. The safety and efficacy of first-line atezolizumab plus bevacizumab in patients with unresectable hepatocellular carcinoma: A multicenter real-world study from Turkey.

12. Prognostic factors for regorafenib treatment in patients with refractory metastatic colorectal cancer: A real-life retrospective multi-center study.

13. Comparison of clinicopathological and survival features of right and left colon cancers.

14. Clinical outcomes and prognostic factors of adult's Ewing sarcoma family of tumors: single center experience.

15. Prognostic Factors in Operated Stage IIIC, Pathological N3a Breast Cancer Patients.

16. Sequential therapy and prognostic factors in metastatic renal cell carcinoma: single centre experience.

17. Adjuvant systemic chemotherapy with or without bevacizumab in patients with resected pulmonary metastases from colorectal cancer.

18. Treatment decision plans matter in elderly patients with gastrointestinal cancer: suboptimal or optimal?

19. Prognostic factors and adjuvant treatments for surgically treated cancers of the biliary tract: a multicentre study of the Anatolian Society of Medical Oncology (ASMO).

20. Effects of comorbidities and functional living activities on survival in geriatric breast cancer patients.

21. Duration of anti-HER2 blockage therapy may improve survival in HER2 positive metastatic breast carcinoma patients.

22. Childhood, adolescents, and young adults (≤25 y) colorectal cancer: study of Anatolian Society of Medical Oncology.

23. Adjuvant systemic chemotherapy with or without bevacizumab in patients with resected liver metastases from colorectal cancer.

24. Multicenter evaluation of patients with cutaneous malignant melanoma in Turkey: MELAS study.

25. Prognostic factors for teenage and adult patients with high-grade osteosarcoma: an analysis of 240 patients.

26. Detection of circulating tumor cells in breast cancer patients: prognostic predictive role.

27. Assessment of general characteristics of patients with primary metastatic breast carcinoma: single center experience.

28. Gemcitabine alone versus combination of gemcitabine and cisplatin for the treatment of patients with locally advanced and/or metastatic pancreatic carcinoma: a retrospective analysis of multicenter study.

29. Prognostic factors in patients with advanced pancreatic cancer treated with gemcitabine alone or gemcitabine plus cisplatin: retrospective analysis of a multicenter study.

30. Clinicopathological features in bilateral breast cancer.

31. An overlooked indicator of disease activity in ulcerative colitis: mean platelet volume.

Catalog

Books, media, physical & digital resources